Cargando…
Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils
Amyloid fibril formation occurs from a wide range of peptides and proteins and is typically associated with a loss of protein function and/or a gain of toxic function, as the native structure of the protein undergoes major alteration to form a cross β-sheet array. It is now well recognised that some...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618248/ https://www.ncbi.nlm.nih.gov/pubmed/28895938 http://dx.doi.org/10.3390/biom7030067 |
_version_ | 1783267146507223040 |
---|---|
author | Garvey, Megan Ecroyd, Heath Ray, Nicholas J. Gerrard, Juliet A. Carver, John A. |
author_facet | Garvey, Megan Ecroyd, Heath Ray, Nicholas J. Gerrard, Juliet A. Carver, John A. |
author_sort | Garvey, Megan |
collection | PubMed |
description | Amyloid fibril formation occurs from a wide range of peptides and proteins and is typically associated with a loss of protein function and/or a gain of toxic function, as the native structure of the protein undergoes major alteration to form a cross β-sheet array. It is now well recognised that some amyloid fibrils have a biological function, which has led to increased interest in the potential that these so-called functional amyloids may either retain the function of the native protein, or gain function upon adopting a fibrillar structure. Herein, we investigate the molecular chaperone ability of α-crystallin, the predominant eye lens protein which is composed of two related subunits αA- and αB-crystallin, and its capacity to retain and even enhance its chaperone activity after forming aggregate structures under conditions of thermal and chemical stress. We demonstrate that both eye lens α-crystallin and αB-crystallin (which is also found extensively outside the lens) retain, to a significant degree, their molecular chaperone activity under conditions of structural change, including after formation into amyloid fibrils and amorphous aggregates. The results can be related directly to the effects of aging on the structure and chaperone function of α-crystallin in the eye lens, particularly its ability to prevent crystallin protein aggregation and hence lens opacification associated with cataract formation. |
format | Online Article Text |
id | pubmed-5618248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56182482017-09-29 Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils Garvey, Megan Ecroyd, Heath Ray, Nicholas J. Gerrard, Juliet A. Carver, John A. Biomolecules Article Amyloid fibril formation occurs from a wide range of peptides and proteins and is typically associated with a loss of protein function and/or a gain of toxic function, as the native structure of the protein undergoes major alteration to form a cross β-sheet array. It is now well recognised that some amyloid fibrils have a biological function, which has led to increased interest in the potential that these so-called functional amyloids may either retain the function of the native protein, or gain function upon adopting a fibrillar structure. Herein, we investigate the molecular chaperone ability of α-crystallin, the predominant eye lens protein which is composed of two related subunits αA- and αB-crystallin, and its capacity to retain and even enhance its chaperone activity after forming aggregate structures under conditions of thermal and chemical stress. We demonstrate that both eye lens α-crystallin and αB-crystallin (which is also found extensively outside the lens) retain, to a significant degree, their molecular chaperone activity under conditions of structural change, including after formation into amyloid fibrils and amorphous aggregates. The results can be related directly to the effects of aging on the structure and chaperone function of α-crystallin in the eye lens, particularly its ability to prevent crystallin protein aggregation and hence lens opacification associated with cataract formation. MDPI 2017-09-12 /pmc/articles/PMC5618248/ /pubmed/28895938 http://dx.doi.org/10.3390/biom7030067 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Garvey, Megan Ecroyd, Heath Ray, Nicholas J. Gerrard, Juliet A. Carver, John A. Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title | Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title_full | Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title_fullStr | Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title_full_unstemmed | Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title_short | Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils |
title_sort | functional amyloid protection in the eye lens: retention of α-crystallin molecular chaperone activity after modification into amyloid fibrils |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618248/ https://www.ncbi.nlm.nih.gov/pubmed/28895938 http://dx.doi.org/10.3390/biom7030067 |
work_keys_str_mv | AT garveymegan functionalamyloidprotectionintheeyelensretentionofacrystallinmolecularchaperoneactivityaftermodificationintoamyloidfibrils AT ecroydheath functionalamyloidprotectionintheeyelensretentionofacrystallinmolecularchaperoneactivityaftermodificationintoamyloidfibrils AT raynicholasj functionalamyloidprotectionintheeyelensretentionofacrystallinmolecularchaperoneactivityaftermodificationintoamyloidfibrils AT gerrardjulieta functionalamyloidprotectionintheeyelensretentionofacrystallinmolecularchaperoneactivityaftermodificationintoamyloidfibrils AT carverjohna functionalamyloidprotectionintheeyelensretentionofacrystallinmolecularchaperoneactivityaftermodificationintoamyloidfibrils |